首页 > 产品目录 > 信号通路 > Immunology & Inflammation > NOD-like Receptor (NLR) > MCC950 Sodium (CP-456773 Sodium)

MCC950 Sodium (CP-456773 Sodium)

ChemLeader 98+%

MCC950 Sodium (CP-456773 Sodium)

产品编号：CL1969 CAS No.：256373-96-3 MDLNo： 分子式：C20H23N2NaO5S 分子量：426.46

加入收藏分享给朋友

规格	库存	目录价	会员专享价	数量
5 mg	In-stock	￥450.00	登录后可见	- +
10 mg	In-stock	￥800.00	登录后可见	- +
25 mg	In-stock	￥1350.00	登录后可见	- +
50 mg	In-stock	￥2430.00	登录后可见	- +

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

下载COA

发送询价加入购物车

基本信息
相关文档
产品详情
相关文献

基本信息

英文名称	MCC950 Sodium (CP-456773 Sodium)
中文名称	MCC950 Sodium (CP-456773 Sodium)
CAS号	256373-96-3
分子式	C20H23N2NaO5S
分子量	426.46
外观	Off-white to yellow powder
储存条件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

产品详情

MCC950 is an inhibitor of NOD-like receptor protein 3 (NLRP3) inflammasome activation. It inhibits ATP-induced IL-1β release in LPS-primed mouse bone marrow-derived macrophages (BMDMs; IC50 = 7.5 nM), as well as cytosolic LPS-induced IL-1β release in Pam3CSK4-primed mouse BMDMs at 0.1 and 1 µM, indicating inhibition of both canonical and non-canonical NLRP3 inflammasome activation, respectively. MCC950 is selective for NLRP3 over NLRC4 and absent in melanoma 2 (AIM2) inflammasomes and does not inhibit LPS-induced NLRP3 priming in mouse BMDMs at 10 µM. It reduces ox-LDL-induced increases in caspase-1 activity and inhibits pyroptosis in THP-1 macrophages when used at a concentration of 1 µM. MCC950 (10 mg/kg) reduces myocardial fibrosis in mice following myocardial infarction induced by left coronary artery ligation. It improves forelimb grip strength and reduces spinal edema in a mouse model of spinal crush injury at the same dose.